Teleflex Announces First Quarter 2022 Earnings Conference Call Information
Teleflex Incorporated (NYSE:TFX) announced a conference call scheduled for 8:00 a.m. Eastern Time on April 28, 2022, to discuss its first quarter 2022 results and provide an operational update.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teleflex Incorporated (NYSE:TFX) announced a conference call scheduled for 8:00 a.m. Eastern Time on April 28, 2022, to discuss its first quarter 2022 results and provide an operational update. Interested participants can register through a specified link, and a replay of the call will be available starting at 11:00 a.m. on the same day. Teleflex focuses on innovative medical technologies across various fields, including vascular access and anesthesia, aimed at improving health outcomes.
Details
News Market Reaction – TFX
The recorded move for TFX in the trading session of this news was -0.44%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WAYNE, Pa., April 14, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter 2022 results, and provide an operational update at 8:00 a.m. Eastern Time on Thursday, April 28, 2022.
To register for the conference call and receive dial-in information, please use the following link: https://www.incommglobalevents.com/registration/q4inc/10646/teleflex-q1-2022-earnings-conference-call/. The call can also be accessed through a live audio webcast on the company’s website teleflex.com.
An audio replay of the call will be available beginning at 11:00 am Eastern Time on April 28, 2022, either on the Teleflex website or by telephone. The call can be accessed by dialing 866-813-9403 (U.S.), or 226-828-7578 (Canada), or +44 204 525 0658 (International). The access code is 682622.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.
Contacts:
Teleflex Incorporated:
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
John Hsu, CFA
Vice President, Investor Relations
investor.relations@teleflex.com
610-948-2836
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.